• image two
  • image three
  • image three
  • image three

IPR Strength

Significant breakthrough products:

  • Cefixime Plus with Microencapsulation technology
  • In-situ Gel Delivery System of Injectable Antibiotics
  • Topical Delivery System of Injectable Antibiotics

Patents granted by the IPO

(We have international patents in pre-grant status for the same inventions)

  • 10 Patents have been granted so far
  • 5 Patents have been out-licensed so far.

Patents in pre-Grant status

  • 30 divisional patents in Antidiabetic Therapy;
  • 12 Patents in Antibiotics
  • 48 divisional patents in Cardiovascular Therapy
  • 10 divisional patents in Nutraceuticals